In 2023, Ireland dominated the European market for antisera and vaccines production, contributing the largest share, succeeded by Belgium, France, and Germany. Notably, Belgium exhibited a significant growth of about 80%, whereas France and the United Kingdom saw declines. Sweden reported a robust increase while other countries like Austria, Portugal, and Greece showed stability in their market shares. The data highlights market expansions in some regions contrast with contractions in others.
Future trends to monitor include Belgium’s sustainability of its remarkable rise and Ireland’s ability to maintain its leadership position. Additionally, emerging markets, like Sweden, could potentially reshape the European landscape with their growth trajectory.
Top countries in Sold Production of Antisera and Vaccines Share by Country (Euros)
| # | 10 Countries | Percent | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Ireland | 60.7 | 2023 | +6.08% | +5.81% | View data |
| 2 | 2 Belgium | 14.09 | 2023 | +0.089% | +79.56% | View data |
| 3 | 3 France | 7.15 | 2023 | +2.55% | -7.99% | View data |
| 4 | 4 Germany | 6.07 | 2023 | +2.13% | -0.34% | View data |
| 5 | 5 Sweden | 5.22 | 2023 | +13.55% | +22.92% | View data |
| 6 | 6 United Kingdom | 2.38 | 2023 | +2.08% | -2.4% | View data |
| 7 | 7 Spain | 2.12 | 2023 | +3.34% | -2.69% | View data |
| 8 | 8 Italy | 1.47 | 2023 | +1.78% | +8.02% | View data |
| 9 | 9 Hungary | 0.34 | 2023 | +2.54% | +4.19% | View data |
| 10 | 10 Finland | 0.18 | 2023 | +6.48% | +1.66% | View data |
